Quarterly report [Sections 13 or 15(d)]

Cash, Cash Equivalents, and Marketable Securities - Schedule of Company???s Investments (Details)

v3.26.1
Cash, Cash Equivalents, and Marketable Securities - Schedule of Company’s Investments (Details) - USD ($)
$ in Thousands
Mar. 31, 2026
Dec. 31, 2025
Cash [Member]    
Schedule of Company’s Investments [Line Items]    
Amortized Cost Basis $ 37,371 $ 24,172
Unrealized Gains
Unrealized Losses
Estimated Fair Value 37,371 24,172
Investments in corporate bonds [Member]    
Schedule of Company’s Investments [Line Items]    
Amortized Cost Basis 17,210 12,072
Unrealized Gains 5
Unrealized Losses   (1)
Estimated Fair Value 17,215 12,071
Total cash, cash equivalents and investments in marketable securities [Member]    
Schedule of Company’s Investments [Line Items]    
Amortized Cost Basis 54,581 41,270
Unrealized Gains 5
Unrealized Losses (1)
Estimated Fair Value $ 54,586 41,269
U.S. Treasury Bills [Member]    
Schedule of Company’s Investments [Line Items]    
Amortized Cost Basis   3,449
Unrealized Gains  
Unrealized Losses  
Estimated Fair Value   3,449
Money Market [Member]    
Schedule of Company’s Investments [Line Items]    
Amortized Cost Basis   1,577
Estimated Fair Value   $ 1,577